COVID-19

Cosmos Health’s Cana Secures Contract Manufacturing Agreement with Australia’s Humacology for up to 500,000 CBD Units Annually

CHICAGO, IL / ACCESSWIRE / July 9, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…

1 year ago

Clinion Applauded by Frost & Sullivan for Enabling Interoperability and Continuity in Clinical Trials Management with its eClinical Solutions

Clinion's decentralized clinical trials and innovative eClinical platform enhance accessibility, cost efficiency, ease of use, regulatory compliance, and sustainability in…

1 year ago

Sonoma Pharmaceuticals Celebrates 20 Years of Selling Wound Care Products in Europe and Announces New Distributor in Ukraine

BOULDER, CO / ACCESSWIRE / July 9, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing…

1 year ago

Zomedica Expands Global Reach Through Strategic Alliance with Leader Healthcare Group for Sales Expansion in Key International Markets

Leader Healthcare Group is Chosen as Distribution Partner to Launch Zomedica® Products into the Gulf Cooperation Council Countries in the…

1 year ago

Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial

Baptist Hospital of Miami is the second site to perform clinical procedures as part of the Company’s Pivotal Human Clinical…

1 year ago

Seyltx Announces Results of Electronic Health Record Analysis to Determine the Prevalence of Refractory Chronic Cough

- Data will be presented at the London International Cough Symposium on July 18, 2024 - 54,958,289 adult patients in…

1 year ago

Symbeo partners with Amazon Business to extend the reach of its RapidInvoice AP automation solution

Symbeo launches RapidInvoice on Amazon Business’s Market App Center for B2B ecommerce with a solution that enhances AP functions and…

1 year ago

Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial

The first clinical case was performed at Brigham and Women’s Hospital The clinical trial is expected to support the future…

1 year ago

ORYZON Receives “Decision to grant” for Two Important Patents for Vafidemstat in Japan

For the treatment of Borderline Personality Disorder (BPD) and Attention Deficit Hyperactivity disorder (ADHD)MADRID and CAMBRIDGE, Mass., July 08, 2024…

1 year ago

Olink Announces Receipt of CMA Clearance for Proposed Acquisition by Thermo Fisher

UPPSALA, Sweden, July 08, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that the UK…

1 year ago